Centene Corporation

CNC Healthcare Healthcare Plans

Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

68.86 1.84 +2.75%
Market cap
$33.1B
P/E
0.0×
Fwd P/E
24.8×
Dividend yield
—
F-score
5/9
Altman Z
2.64
Beneish M
−3.07
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.16 0.08 0.10 0.09
P/FCF ratio
3.54 2.27 4.70 5.22
P/Operating CF
8.83 3.69 46.43 12.92
P/B ratio
1.40 0.75 1.01 0.83
EV/Sales
0.10 0.04 0.09 0.09
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
2.32 1.23 4.02 4.73
Current Ratio
1.15 1.12 1.10 1.08
Net Debt/EBITDA
(7.31) (3.41) 2.06 0.25
Debt/Equity
0.71 0.76 0.87 0.84
Earnings Yield
(16.20%) (40.07%) (33.07%) (30.27%)
Free Cash Flow Yield
28.24% 44.15% 21.29% 19.15%
Free Cash Flow per Share
6.92 8.47 0.45 2.33
Book value per Share
45.83 43.70 40.63 42.82
Free Cash Flow
3,416.00 4,166.00 224.00 1,145.00
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates